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Abstract
The performance of filamentous fungi in submerged cultivation
determines their suitability for large-scale industrial biotech-
nology processes and is the result of complex interplay between
the physical and chemical parameters of the process and the
cellular biology of the fungi. Filamentous fungi have a natural
ability to degrade complex substrates through secretion of a
large number of diverse enzymes and to produce a number of
metabolites that inhibit or prevent the growth of other species
in the surroundings. These features have been exploited by
industry, resulting in multi-billion dollar processes for pro-
ducing enzymes and metabolites of value. However, the wealth
of diversity of these species is still not fully represented in
large-scale bioprocesses, and thus advancement from discov-
ery to application is one of the challenges for modern bio-
technology. Acceleration of the process can be achieved
through integrated approaches for assessing cellular perfor-
mance (quantitative physiology), genetic modification of
strains (metabolic engineering), and omics analyses and
modeling (systems biology). In this review, we evaluate state-
of-the-art of filamentous fungal applications in industrial bio-
technology , focusing on physiological aspects of the fungi that
provide the basis of their cellular performance. We also discuss
the advancement of systems biology approaches and how the
establishment of these tools for fungal research has begun to
reveal the possibilities for further exploitation of these or-
ganisms. Increased future focus on multicellular physiology
and relevant assays will lead to fungal cells and processes that
are customizable to a greater degree, finally allowing the full
potential of these complex organisms and their product di-
versity to unfold.
Introduction
I
nprokaryotes (such as Escherichia coli) and yeast (such as
Saccharomyces cerevisiae), systems biology approaches
have been well developed in the post-genomic era—S.
cerevisiae was sequenced in 1996, followed by E. coli in
1997.1–2 Quantification of physiological features was achieved
by applying a variety of highly advanced techniques and tools
for studying and manipulating the biological systems responsi-
ble for production of desirable metabolites. Subsequent
modeling—in particular, by combining transcriptomic, meta-
bolomic, and proteomic data— provided the necessary basis for
powerful advances in our holistic understanding of these or-
ganisms.3 With more than 1,300 articles in the literature since
2000 that include both the terms ‘‘yeast’’ and ‘‘systems biology,’’
the application of systems biology approaches in yeast is clearly
well established. Systems biology research involving filamen-
tous fungi lags behind, however, partly because whole genome
sequencing of these organisms (Neurospora crassa, Aspergillus
oryzae, Aspergillus niger, Trichoderma reesei, Penicillium
chrysogenum) took place much later than for other organisms,
and partly due to the challenges inherent in working with sub-
merged cultivation (fermentation) of multi-cellular fungi in re-
producible and standardized ways—an essential requirement for
the statistical methods applied to interpret the ‘‘omes.’’4–8
Much of the research until now has been based on metabolic
engineering approaches and genetic manipulation involving
single genes, which, while providing valuable data, are not
sufficient for integrated systems biology approaches. To ad-
vance these approaches in filamentous fungi, further develop-
ment of models and improved data integration are required.
Carefully designed and controlled, reproducible cultivation
techniques that produce the tailor-made biomass needed to de-
fine cellular physiology under specific conditions are of equal
importance. To obtain high-quality data from omics analyses,
the cultures must be grown under tightly regulated and con-
trolled conditions, harvested and stored using methods that
preserve their metabolic state, and then be processed for use in
advanced assays.
Considerable advances in lab-scale fungal cultivation tech-
niques were made over the last 10–15 years as our understanding
of how to cultivate organisms for optimal characterization or
performance improved. Highly reproducible, replicate bioreac-
tor experiments that provide quality biomass can now be per-
formed with filamentous fungi, thus tackling one of the major
challenges in the field.9–13 It is therefore not a coincidence that
the terms Aspergillus and systems biology are now appearing
together with greater frequency in the literature, in 83 articles
published since 2007, where the first genomes were published.
Although the gap between yeast and filamentous fungi remains,
it is clear that systems biology approaches in filamentous fungi
are increasing exponentially. In this review, we highlight the
progress in quantitative fungal physiology and omics-driven
analytical tools and how merging these disciplines can
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accelerate integrated approaches for in-depth characterization of
fungal cell factories.
Cellular Performance of Established
Fungal Cell Factories
Filamentous fungi have served as industrial cell factories for
more than half a century, and large-scale processes based on
these organisms are therefore well established. The broad ap-
plication of filamentous fungi in industry covers biochemicals,
proteins, and pharmaceuticals.14–18 Examples include the citric
acid production process using A. niger and penicillin production
using P. chrysogenum, in which incremental improvements and
new insights have been documented over many decades.15,19–24
The characterization of filamentous fungal hosts for expression
of proteins also dominates the literature, and this field has been
thoroughly reviewed in recent years.18,25
CELL FACTORY CHARACTERISTICS
While Penicillium is still recognized for its production of
various beta-lactams in very high yields, the genus Aspergillus is
widely used in industry for the production of both organic acids
and enzymes.25–26 T. reesei is the organism of choice for pro-
duction of cellulolytic enzymes, as it exhibits high levels of
secretion and harbors more than 200 genes for polysaccharide-
degrading enzymes.27 Organism specialization is, of course,
partly dependent on the genetic background. Penicillium species
have been domesticated for large-scale antibiotic production
through intense strain improvement programs and selection for
morphological types that ease cultivation and processing.28
Aspergilli have been exploited for their production and secretion
of organic acids; they are particularly attractive for this appli-
cation because they tolerate low pH and process conditions can
determine which acid(s) are produced. The versatility of this
genus is further underlined by the fact that Aspergilli are used
to produce more than 60% of the industrial enzymes made
with filamentous fungi.29 Their capability for glycosylation
and proper protein processing offers advantages for these
applications.30
As indicated above, many decades of research have led to the
use of filamentous fungal production hosts (cell factories) in
modern industrial biotechnology. These strains have been se-
lected and highly adapted to the specific conditions of the pro-
cesses to which they are applied. The interplay between the
physical and chemical parameters of a production process and
the biological properties of the cell complicate cell-factory se-
lection.31 Morphology also poses a challenge due to the fila-
mentous nature of the growth and the differentiation of cellular
compartments as hyphae extend.32,33 This leads to heterogeneity
in terms of the morphological forms present and the cell
(compartment) types that contribute to the overall performance
of the culture.34 The challenge is to balance cellular potential,
process design, and economic feasibility. High broth viscosities,
and thus low oxygen mass transfer, are the main physical factors
governing protein productivity in filamentous fungal cultiva-
tions. These have been optimized by applying specific feeding
strategies to improve glucoamylase production by both A. or-
yzae and A. niger.11,35
Based on these considerations, and with a focus on the cellular
biology, the characteristics of desirable filamentous fungal cell
factories are summarized in Table 1, with the listed advantages
driven by process economics and the need for viable large-scale
operation.36
IMPROVING CELL FACTORIES
To improve our understanding of established cell factories in
expanded applications, or to extend novel fungal species to the
realm of industrial biotechnology, methodologies to ensure that
analyses can be performed accurately on cells arising from spe-
cific and controlled cultivation environments need to be devel-
oped. Cellular performance is the term used to define the
capabilities of a cell under a specific set of cultivation conditions;
it facilitates the comparison and evaluation of different species or
differing conditions. Classical parameters of physiological char-
acterization—growth rate, yield, and productivity estimation—
are the cornerstone of cellular performance assessment.
Metabolic engineering has enabled significant improvements
in cell factory efficiency by targeting and examining the effects of
genetic modifications that lead to improved cell factory charac-
teristics.37–39 In multiple rounds of strain design, genetic modi-
fication and analysis of the resulting cellular physiology have led
to sequential improvement and led to filamentous fungi as highly
efficient cell factories. The directed approaches of metabolic
engineering have been the main strategy for tackling substrate-
utilization issues, improving product yield, eliminating unwanted
by-products, and introducing or extending metabolic pathways.
The product spectrum continues to expand as processing know-
how and understanding of cellular physiology improves.40–45 To
this end, metabolic models, control analysis, and flux analysis
using 13C-labelled substrates have been employed for bench-
marking strains and quantifying the consequences of genetic
modifications on metabolism.46–52 These approaches were de-
veloped and established before genome sequences were available,
but are still valid in the post-genome era.
Table 1. Desirable Cell-Factory Characteristics and the
Advantages They Confer for Industrial Applications36
DESIRABLE CELL-FACTORY
CHARACTERISTICS ADVANTAGES
Efficient substrate utilization Lower production costs
Wide substrate range Tunable process in terms of substrate
availability
High degree of product secretion and
product stabilization
Ease of downstream processing
High yield and productivity Increased profit margin of process
Minimized by-product formation Simplified product recovery and
improved process economy
Morphology suited for bioreactor pro-
cesses
Preferred morphology depending on
product; simplified process operation
Amenable to genetic modification Targeted alterations can be achieved
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Non-direct approaches, such as evolutionary engineering, can
also be applied when substrate tolerance or product toxicity are
an issue.53 While these techniques are well established for
yeast—particularly with regard to mixed sugar utilization—to
our knowledge, applications in filamentous fungi have not yet
been demonstrated.54,55
Even in modern fungal biotechnology, basic approaches to
parameter estimation are still the foundation for most quantita-
tive fungal physiology studies. The standard for detailed phys-
iological characterization was set in the late 1990s and is
exemplified in studies that employ different cultivation modes
to study various physiological states.56–58 Such studies provided
highly reproducible data on growth rates, yield coefficients, and
productivity, allowing an assessment of conditions for optimal
cellular performance.
As highlighted above, metabolic engineering is a useful sys-
tematic method in which strains are constructed through genetic
engineering with the aim of introducing/improving desirable
cell factory characteristics (Table 1). However, cellular ro-
bustness, derived from enzyme redundancies and complex
regulatory circuits, often enables the cell to counteract the ge-
netic modifications. For this reason, systems biology approaches
have become increasingly popular to assist in the identification
of targets for genetic engineering. The increasing number of
available genomes in particular has enabled the shift to data
integration from several omics techniques, which facilitates a
holistic view of cellular functions. Omics-driven analyses are
rapidly becoming an essential approach to evaluation of genetic
regulation that underlies quantified metabolic responses.
Omics-Driven Cell Factory Characterization
Systems biology approaches for cell factory characterization
of filamentous fungi that incorporate gene expression analysis
are rapidly emerging.39,59–61 This section will, therefore, con-
centrate on genome-wide analyses and the integration of tran-
scriptomics data with physiological characterization in
submerged cultivations. An overview of selected studies is
provided in Table 2.9,62–84 Omics studies that have investigated
desirable cell factory characteristics can be broadly grouped into
three categories: efficient carbon utilization; high yield; and
efficient product secretion. Aspergilli are known for their ability
to utilize a broad range of substrates and to use these substrates
efficiently. They are also able to maximize their energy pro-
duction through the stringent coordination of regulatory net-
works for carbon-source utilization. Fungal cultivation
physiology coupled with transcriptomics has been used to pro-
vide valuable insight into regulatory responses caused by single
substrates, combinations of substrates, and complex carbon
substrates.
EFFICIENT CARBON UTILIZATION
Bioconversion of a wider range of substrates is becoming
increasingly relevant as biosustainability becomes a require-
ment in process design. Transcriptomics also has an important
role to play in the identification of genes required for efficient
catabolism of carbon sources present in complex and waste
substrates.68,71–74 Due to the abundance of xylose in hemicel-
lulose, the regulatory mechanisms involved in using this carbon
source as opposed to glucose have been investigated in three
different Aspergilli. One study developed and validated a
method for transcriptome analysis of Aspergilli, and allowed
identification of conserved gene responses to growth on glucose
and xylose in A. niger, A. oryzae, and A. nidulans.85 This tech-
nique was used to provide a comparison of A. oryzae and A.
niger growing on maltose, which is utilized in industrial pro-
cesses as an effective inducer of enzyme production.69 The
study illustrated the routes for maltose transport and metabo-
lism and revealed how maltose may affect gene expression,
pointing toward targets for improved protein secretion. In an-
other study, glycerol metabolism was investigated in three As-
pergillus species, leading to the identification of possible
regulatory binding sites, as well as giving insights into cross-
species evolution.73
Carbon catabolite repression, the regulatory mechanism that
controls carbon utilization, is mediated by transcription factor
regulators, including the CreA protein. In one of the first studies
to employ a DNA microarray of an Aspergillus species, tran-
scription analysis of wild type and creA mutant A. nidulans
strains was performed, and growth on glucose and ethanol was
compared.86 This work gave an overview of the global response
caused by CreA and highlighted the advantage of large-scale
transcriptional analysis for studying broadly acting transcrip-
tional regulators such as CreA (Table 2).
HIGH YIELD AND IMPROVED PRODUCT SECRETION
High yield and efficient secretion capacity are key criteria
when expression hosts are being considered for an industrial
process. In a study to assess the physiological characterization of
A. niger grown in chemostats with xylose or maltose as the
limiting substrate and growth controlled at the same rate.80
The data obtained included transcription profiles and an esti-
mation of quantitative physiological parameters. The increased
secretion potential on maltose was related to the induced tran-
scription of more than 90 genes that regulate protein secretion,
leading to the identification of putative regulatory elements and
a greater understanding of the secretory pathway in filamentous
fungi.
High-yielding strains have also been the subject of tran-
scriptomics studies investigating the response of process phys-
iology to protein over-expression. One example is a study on
the effect of glucoamylase over-expression in maltose-limited
chemostats through transcriptomics.80 A notable finding was the
identification of a set of only 40 differentially expressed core
genes that ensure high protein traffic through the secretory
pathway. In a study of T. reesei, gene expression was correlated
to protein production rate in chemostat cultures at a range of
specific growth rates.78 This work allowed for the identification
of biosynthetic activities with positive and negative effects on
protein production and indicated possible regulatory mecha-
nisms in the observed physiological responses.
While studies on Aspergilli and T. reesei have centered on
carbon metabolism and productivity, Penicillium research has
focused on secondary metabolite production, with emphasis on
the biosynthetic pathways and product spectrum expansion
(Table 2).
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Table 2. Overview of Omics-Driven Cell Factory Characterization in Filamentous Fungi
STRAIN AIM OF STUDY CULTIVATION TYPE OMICS APPLIED
b-Lactam Production
Penicillium chrysogenum Relation between central metabolism
and penicillin biosyntheses
Chemostats, reactor Metabolomics62
P. chrysogenum Characterization of protein changes
caused by strain improvement
Batch, flasks Proteomics63
P. chrysogenum Characterization of metabolic changes
during industrial production
Batch, reactor (large scale) Metabolomics64
P. chrysogenum Reduction of side-chain degradation Chemostats, reactor Transcriptomics65
P. chrysogenum Reduction of side-chain degradation Chemostats, reactor Transcriptomics66
P. chrysogenum Expansion of product spectrum Chemostats, reactor Transcriptomics67
Enzyme production
Aspergillus niger Mechanisms for degrading lignocellulose Batch, flasks RNA-seq68
A. niger and Aspergillus oryzae Maltose utilization Batch, reactor Transcriptomics69
Trichoderma reesei Carbon catabolite repression Chemostats, reactor Transcriptomics70
T. reesei Transcriptional response to lignocellulose Batch, flasks Transcriptomics71
T. reesei Comparative proteomics on cells grown on
different carbon sources
Batch, reactors Proteomics72
Aspergillus spp Glycerol metabolism in Aspergillus Batch, reactor Transcriptomics73
A. niger Enzyme expression on sugarcane bagasse Batch, flasks Transcriptomics74
A. niger Enzyme expression on six different plant
mono- and polysaccharides
Batch, flasks Transcriptomics75
A. oryzae Effects on metabolism of alpha-amylase
overexpression
Batch, reactor Transcriptomics76
A. niger Secretory response to D-maltose and
D-xylose
Batch, reactors Proteomics77
T. reesei Correlating gene expression and protein
production rate
Chemostats, reactor Transcriptomics, proteomics78
A. niger The effect of enzyme overexpression
using maltose as carbon source
Chemostats, reactor Transcriptomics79
A. niger Expression on xylose or maltose Chemostats, reactors Transcriptomics80
A. niger Proteomics on cells from maltose and
xylose media
Batch, reactors Proteomics81
Organic acid production
A. niger The effect of transcription factor
modulation on acid production
Chemostats Transcriptomics9
A. niger Acid production profile as a function
of pH
Batch, reactor Transcriptomics82
A. oryzae Malic acid production during nitrogen
starvation conditions
Batch, reactor Transcriptomics83
A. terreus Identification of genes crucial for
itaconic acid production
Batch, reactor Transcriptomics84
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TAILOR-MADE BIOMASS FOR OMICS ANALYSES
The common factor in the omics-driven cell factory analysis
studies reviewed above is the controlled cultivation techniques
that produce tailor-made biomass specifically for the various
approaches employed. Obtaining biomass through standardized
cultivations in bioreactors, where the physiological parameters
can be estimated and integrated with omics data, is a growing
trend. It must be stressed that the quality of the omics data
depends on the quality and reproducibility of the cultivations,
which provide an accurate snapshot of metabolism at a given
point in time and have definable physical, chemical, and phys-
iological conditions.
Figure 1 outlines the boundaries and interplay between
the various approaches that are useful for investigating and
quantifying the cellular performance of industrially relevant
microorganisms. Quantitative physiology still forms the
knowledgebase in terms of overall culture performance, and
essentially directs selection of the biomass for further charac-
terization of strains. This biomass can be utilized directly in
omics analyses, but it is often advantageous to employ strain
modification in one or more rounds of metabolic engineering
before analyses are performed. In this extended cycle, systems
biology techniques allow for data integration of all analyses with
genome sequences, and models can form the basis for predicting
targets for further improvement in cellular performance.
Previous studies have relied mainly on batch or continuous
culture to obtain biomass for omics analysis. However, the use
of state-of-the-art controlled cultivations in combination with
omics has found an important role in work employing repro-
ducible carbon- and energy-limited retentostat cultures. These
have been applied to study the transcriptional response of A.
niger at growth rates approaching zero.80 Related studies by the
same group focused on carbon starvation and showed a corre-
lation between transcriptomics analysis and the morphological
development of the culture—leading to the proposition of a
model for the carbon starvation response of A. niger.10
While integration of process data, physiological character-
ization, and transcriptomics analysis is well advanced, further
application of the knowledge gained from genome-wide ana-
lyses should be the next goal for systems biology approaches in
filamentous fungi. Increasing the scale of data integration efforts
to combine more systems biology disciplines, such as pathway
reconstruction, metabolomics, metabolic flux analysis, pro-
teomics, and transcriptomics—as opposed to the currently pre-
dominant single-methodology studies—is required to move to a
systemic understanding of cell factories. Substantial leaps for-
ward could also be made by more efficiently utilizing the omics
data already available and applying this information to make
targeted improvements in cell factories already employed in
industrial processes. A particularly overlooked aspect of fila-
mentous fungi is the complexity derived from their essentially
multicellular nature, which could benefit greatly from targeted
multi-omics efforts to develop completely designable and cus-
tomizable submerged bioreactor cultivations.
Conclusions
Systems biology approaches based on tailor-made biomass
from highly controlled cultivations are now established, and,
combined with the development of advanced techniques and
tools for studying cellular performance, can provide a deeper
understanding of potential uses of filamentous fungi in indus-
trially relevant processes. We predict that the next decade of
research on these complex cell factories will see significant
advancements. In particular, the integration of omics-based
technologies will drive substantial development in our ability
to customize fungal cell factories and
their processes. Increased knowledge of
cellular performance will allow these
processes to be more tunable, as it be-
comes increasingly possible to modify
cultivation parameters and in wider in-
tervals than used in currently employed
processes.
Furthermore, we believe that the na-
tive product diversity within filamentous
fungi should be further exploited to
bring forward new candidates with po-
tential applications in biosustainable
processes. In addition to the ongoing
discovery of new enzymes for the deg-
radation of complex biomass, the field
can move further into the conversion of
complex substrates into new value-ad-
ded products from fungal secondary
metabolism, e.g., pigments and flavor
compounds.
The current and future impact that
the reduced cost of genome sequencing
has had in advancing applications of
filamentous fungi cannot be overstated.
Fig. 1. The boundaries and interplay between quantitative physiology, metabolic engineering,
and systems biology approaches in analysis of cell factory performance.
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Access to the genome sequence of the cell factory of choice
greatly extends the possibilities of physiological characteriza-
tion and analysis with all omics-derived technologies. The
ability to sequence more fungal genomes generates the possi-
bility of new heterologous products from both enzymes and
fungal metabolism. The ways in which genome sequencing are
being employed have also started to change the traditional in-
dustrial biotechnology approaches to mutation/selection cycles.
This method has proven highly effective for generating efficient
producer strains, and can now be further rationalized with back-
sequencing to identify beneficial mutations for reinsertion into
platform strains.
In conclusion, we find that cellular performance evaluation
and characterization should focus on multicellular physiology
and the development of reliable screening assays and methods
for detailed characterization using omics and high-throughput
analytical methods. If this is accomplished, fungal cell factories
and processes can become highly customizable, utilize fungal
bioproduct diversity to its full potential, and reduce the time-
frame from product discovery to industrial production.
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